REPL vs RYTM Stock Comparison

RYTM currently leads REPL in this stock comparison, with AIQ scores of 62 vs 60. The clearest difference is risk resilience, while REPL has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 2 points
REPL
Healthcare
vs
RYTM
Healthcare
REPL
Replimune Group, Inc.
Price
$21.89
Day move
-0.41%
AIQ Score
60/100
Best edge
Momentum
Sector
Healthcare
RYTM
Rhythm Pharmaceuticals, Inc.
Leads
Price
$115
Day move
+4.7%
AIQ Score
62/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between REPL and RYTM?

RYTM leads the current stock comparison as Rhythm Pharmaceuticals, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Replimune Group, Inc. vs Rhythm Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

RYTM leads

RYTM leads by 2 AIQ points, primarily on Risk Resilience and Quality. Wall Street currently favors REPL on target upside.

Fragile: 1 of 5 evidence groups support RYTM, and its current signal state is conflicted.

Evidence agreement: 1 of 5Comparison trend: Stable
REPL

Replimune Group, Inc.

AIQ Score
60/100
AIQ Edge Score
10/10
RYTM

Rhythm Pharmaceuticals, Inc.

Leads
AIQ Score
62/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors RYTM over REPL, 62 versus 60 as of Nov 15, 2026. RYTM's advantage is driven primarily by stronger risk resilience and quality, while REPL holds the stronger momentum profile. RYTM also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors REPL. 1 of 5 covered evidence groups favor RYTM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. RYTM lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

Compare Replimune Group, Inc. and Rhythm Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

REPL
-34.2%
RYTM
+858.5%

Price return comparison

Growth of $10,000, price only

REPL $6,580 · RYTM $95,850

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare REPL and RYTM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

REPL advantage
0
RYTM advantage
  • Risk Resilience26 vs 57
    RYTM +31
  • Quality35 vs 60
    RYTM +25
  • Momentum97 vs 72
    REPL +25

1 of 5 evidence groups favor RYTM. RYTM’s edge is concentrated in risk resilience and quality; REPL keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

REPL0 AIQ

No factor moved materially.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.59x)
  • RSI Bearish Divergence — bearish, momentum, medium horizon
RYTM+2 AIQ

Largest factor move: Momentum +4

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon

RYTM's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — REPL and RYTM both carry a full feed there.

The central trade-off

RYTM (Rhythm Pharmaceuticals, Inc.): the stronger current systematic profile, led by risk resilience and quality.

REPL (Replimune Group, Inc.): the counter-case, on momentum, technicals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

RYTM

RYTM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

RYTM

RYTM on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

REPL

REPL on the Momentum factor, by 25 points.

Lower downside

RYTM

RYTM on Risk Resilience, by 31 points.

Analyst upside

REPL

REPL on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors RYTM, analyst targets favor REPL. That disagreement is the most useful thing on this page.

MeasureREPLRYTMNote
Implied upside to target+37%+18.5%REPL has more room
Target dispersion+6.7%+28.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering819Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

1 of 5 covered evidence groups favor RYTM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven60 vs 62
FundamentalsEvenEPS growth 25% vs 16.4%; TTM ROE -27.9% vs -20.5%
ValuationNot coveredNot covered
TechnicalsREPLPrice vs 50-day 48.3% vs 18.7%; vs 200-day 118.9% vs 18.3%
Risk ResilienceRYTMRisk Resilience 26 vs 57
Analyst expectationsREPLTarget upside 37% vs 18.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of REPL and RYTM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
  • Only 1 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on RYTM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

RYTM lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

May 27REPL leads above the line · RYTM leads belowNov 13
Today
RYTM +2
60 vs 62
7 sessions ago
REPL +3
60 vs 57
30 sessions ago
RYTM +4
51 vs 55
90 sessions ago
RYTM +10
52 vs 62

The lead changed hands 2 times in this window, most recently on Nov 2 when REPL moved ahead of RYTM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

REPLConflicted

5 bullish / 3 bearish / 1 neutral, conflicted

Only REPL

  • Golden Cross Active — bullish, trend, long horizon (47.61%)
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • RSI Overbought — bearish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
RYTMConflicted

3 bullish / 3 bearish / 2 neutral, conflicted

Only RYTM

  • Death Cross Active — bearish, trend, long horizon (0.37%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon

Both carry 5 more signals that do not separate them: ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Keltner Channel Breakout, Low Volume Rally Warning, TRIX Bullish Signal.

RYTM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

REPLNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.41%, AIQ 0 points).

RYTMConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +4.7%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1REPL closes the Risk Resilience gap — currently 31 points behind, the largest single contributor to RYTM's edge.
  2. 2REPL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
  3. 3RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricREPLRYTM
Revenue growth (YoY)0%29.3%
EPS growth (YoY)25%16.4%
Gross margin0%88.2%
Operating margin0%-66.7%
Return on equity (TTM)-27.9%-20.5%
Debt to equity0.620.02

Performance

REPL leads 5 of 6 windows
MetricREPLRYTM
1 week (5 sessions)1.2%2.4%
1 month (20 sessions)101.6%33.5%
3 months (63 sessions)49.6%-0.4%
6 months (126 sessions)344%27.1%
Year to date125.2%7.5%
1 year (252 sessions)139.8%17.5%

Technicals

REPL has the stronger structure
MetricREPLRYTM
RSI (14)72.166.3
ADX (14)42.828.5
Price vs 50-day48.3%18.7%
Price vs 200-day118.9%18.3%
Volatility (1M, annualized)100.6%110.9%

Risk

RYTM is the more resilient
MetricREPLRYTM
Beta0.91.24
Sharpe ratio1.30.52
Sortino ratio2.570.89
Max drawdown-84.2%-35.5%
Current drawdown-6%-2.2%
Annualized volatility187.9%54.6%
Value at risk (95%)-8.2%-5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, REPL or RYTM?

On the Algovestiq AIQ Score, RYTM is the stronger of the two as of Nov 15, 2026, scoring 62 against REPL's 60. The edge comes from risk resilience and quality. REPL is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is REPL or RYTM the better buy right now?

RYTM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.

Why does the AIQ Score favor RYTM over REPL?

The composite weights Quality, Value, Momentum and Risk Resilience. RYTM leads Risk Resilience by 31 points; RYTM leads Quality by 25 points; REPL leads Momentum by 25 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, REPL or RYTM?

Analyst price targets imply +37% upside for REPL and +18.5% for RYTM, so the Street currently favors REPL. That points the opposite way to the AIQ Score, which favors RYTM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, REPL or RYTM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, REPL or RYTM?

RYTM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, REPL or RYTM?

REPL on the Momentum factor, by 25 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, REPL or RYTM?

RYTM is the more resilient of the two, so the other name carries the higher downside risk. RYTM on Risk Resilience, by 31 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is REPL more profitable than RYTM?

RYTM leads on the comparable margin measures — gross margin 0% vs 88.2%; operating margin 0% vs -66.7%; ttm roe -27.9% vs -20.5%.

Is RYTM's lead over REPL getting stronger or weaker?

RYTM lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-02, when REPL moved ahead of RYTM.

What would change the REPL vs RYTM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: REPL closes the Risk Resilience gap — currently 31 points behind, the largest single contributor to RYTM's edge; REPL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; RYTM's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about REPL and RYTM?

REPL: 5 bullish / 3 bearish / 1 neutral, conflicted. RYTM: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on REPL is Golden Cross Active (bullish, long horizon). On RYTM it is Death Cross Active (bearish, long horizon).

Compare REPL and RYTM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.